@article{b5f259c9f6f543ec84b5a811ac109506,
title = "Denosumab after total hip arthroplasty – Authors' reply",
author = "Mahatma, {Mohit M.} and Jayasuriya, {Raveen L.} and David Hughes and Nigel Hoggard and Buckley, {Simon C.} and Andrew Gordon and Hamer, {Andrew J.} and Tomouk, {Mohammed W.} and Kerry, {Robert M.} and Richard Eastell and Wilkinson, {Jeremy M.}",
note = "Funding Information: RE declares grants from Alexion, Amgen, Immunodiagnostic Systems, Roche, and Nittobo; and personal fees from Amgen, Immunodiagnostic Systems, Roche, GlaxoSmithKline Nutrition, Mereo, Sandoz, Nittobo, AbbVie, Samsung, Haoma Medica, Elsevier, CL Bio, Foundation for the National Institutes of Health, Viking, University of California San Francisco, Biocon, and Lyramid, outside the submitted work. All authors report a grant from Amgen, in relation to the work discussed here.",
year = "2021",
month = jun,
doi = "10.1016/S2665-9913(21)00142-9",
language = "English",
volume = "3",
pages = "e406--e407",
journal = "The Lancet Rheumatology",
issn = "2665-9913",
publisher = "Elsevier",
number = "6",
}